1. Home
  2. LSEA vs CRVS Comparison

LSEA vs CRVS Comparison

Compare LSEA & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSEA
  • CRVS
  • Stock Information
  • Founded
  • LSEA 2013
  • CRVS 2014
  • Country
  • LSEA United States
  • CRVS United States
  • Employees
  • LSEA N/A
  • CRVS N/A
  • Industry
  • LSEA Homebuilding
  • CRVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • LSEA Consumer Discretionary
  • CRVS Health Care
  • Exchange
  • LSEA Nasdaq
  • CRVS Nasdaq
  • Market Cap
  • LSEA 222.1M
  • CRVS 206.5M
  • IPO Year
  • LSEA N/A
  • CRVS 2016
  • Fundamental
  • Price
  • LSEA $11.25
  • CRVS $4.12
  • Analyst Decision
  • LSEA Buy
  • CRVS Strong Buy
  • Analyst Count
  • LSEA 4
  • CRVS 4
  • Target Price
  • LSEA $13.83
  • CRVS $15.00
  • AVG Volume (30 Days)
  • LSEA 2.5M
  • CRVS 1.4M
  • Earning Date
  • LSEA 07-31-2025
  • CRVS 05-08-2025
  • Dividend Yield
  • LSEA N/A
  • CRVS N/A
  • EPS Growth
  • LSEA N/A
  • CRVS N/A
  • EPS
  • LSEA 0.26
  • CRVS N/A
  • Revenue
  • LSEA $1,567,107,000.00
  • CRVS N/A
  • Revenue This Year
  • LSEA N/A
  • CRVS N/A
  • Revenue Next Year
  • LSEA $2.87
  • CRVS N/A
  • P/E Ratio
  • LSEA $42.98
  • CRVS N/A
  • Revenue Growth
  • LSEA 24.15
  • CRVS N/A
  • 52 Week Low
  • LSEA $5.41
  • CRVS $1.75
  • 52 Week High
  • LSEA $14.04
  • CRVS $10.00
  • Technical
  • Relative Strength Index (RSI)
  • LSEA 84.04
  • CRVS 62.46
  • Support Level
  • LSEA $11.23
  • CRVS $3.68
  • Resistance Level
  • LSEA $11.44
  • CRVS $3.94
  • Average True Range (ATR)
  • LSEA 0.05
  • CRVS 0.22
  • MACD
  • LSEA -0.03
  • CRVS 0.04
  • Stochastic Oscillator
  • LSEA 20.83
  • CRVS 89.09

About LSEA Landsea Homes Corporation

Landsea Homes Corp is a growth-oriented homebuilder focused on providing High-Performance Homes that deliver energy-efficient living in attractive geographies. It is engaged in the design, construction, marketing and sale of suburban and urban single-family detached and attached homes in Arizona, California, Colorado, Florida, Texas, and Metro New York. While It offers a wide range of housing options, it focuses on entry-level and first-time move-up homes and believes its markets are characterized by attractive long-term housing fundamentals. The company's segments include Arizona, California, Colorado, Florida, Metro New York, and Texas. It derives a majority of its revenue from home sales in Florida.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: